Tag: non small cell lung cancer
December 10, 2018
Genetics Outlook 2019: CRISPR Technology Advances
With 2018 coming to a close, here's a look at the biggest genetics trends of the year and what's in...
December 3, 2018
4 Gene Therapy Companies to Watch
What gene therapy companies should be on investors' radar? Here are four promising companies to consider looking at in 2018.
November 13, 2018
CRISPR Trials to Watch in 2018
CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
April 30, 2018
8 Glioblastoma Treatment Stocks
With an average survival rate of 16 months, glioblastoma is the most common and deadly type of brain cancer, accounting... April 26, 2018
Merus Announces Recent Corporate Developments and Financial Results for the Fourth Quarter and Full Year 2017
Merus (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced financial results for the fourth quarter...
April 24, 2018
Pharmaceutical Update: Q1 in Review
What happened in Q1 2018 for the pharma industry? Here's a look back at some of the quarter's biggest news...
April 19, 2018